Skip to main content
FinSpry Logo
FinSpry
PRQR logo
PRQR
(NASDAQ)
ProQR Therapeutics N.V.
$2.07-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ProQR Therapeutics (PRQR) Stock Price & Financial Analysis

ProQR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.06 - $2.11
52-Week High$3.10
52-Week Low$1.33
Open$2.06
Volume368.45K
Average Volume (3M)859.93K
Market Cap218.10M
Shares Outstanding105.36M
Price to Sales (P/S)13.94
Price to Book (P/B)4.98
EV/EBITDA-2.91
Revenue (TTM)15.64M
Net Income (TTM)-53.15M
Free Cash Flow (TTM)-57.30M
EPS (TTM)$-0.50
Profit Margin-339.75%
Operating Margin-345.66%
Return on Equity (ROE)-121.44%
Debt to Equity0.36
50-Day MA$1.91
200-Day MA$1.79
52-Week Change-15.51%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ProQR Therapeutics

What is the current stock price for PRQR?

As of the latest trading session, PRQR stock trades at $2.07. The 52-week range is $1.33–$3.10, with a day range of $2.06–$2.11.

What is the P/E ratio for PRQR?

The P/E ratio (Price-to-Earnings) for PRQR is shown in the Key Statistics section. This valuation metric helps compare ProQR Therapeutics N.V. to industry peers.

Does PRQR pay dividends?

ProQR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRQR?

Based on 5 analysts, the consensus for PRQR is Buy.

What is the market cap of PRQR?

ProQR Therapeutics's market capitalization is $218.1M, classifying it as a micro-cap company. ProQR Therapeutics operates in the Healthcare sector within the Biotechnology industry.